Amrina Mohamad Amin1, Nur Balqis Sabri2, Sabariah Md Noor1*, Fezah Othman2, Mamat Hamidi Kamalludin3
1. Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
2. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
3. Institute of Tropical Agriculture and Food Security (ITAFoS), Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
*Corresponding author: Sabariah Md Noor.
ABSTRACT
INTRODUCTION: Cardiovascular disease (CVD) remains the leading global cause of death, highlighting the need for improved risk prediction. Monocyte subsets—classical (CD14⁺⁺CD16⁻), intermediate (CD14⁺⁺CD16⁺), and non-classical (CD14⁺CD16⁺⁺)—have distinct roles in atherosclerosis and prognostic value in cardiovascular outcomes. Their use as biomarkers may enhance existing risk stratification models.
OBJECTIVE(S): This study evaluated the stability and expression of monocyte subsets in long-term cryopreserved peripheral blood mononuclear cells (PBMCs) for retrospective CVD risk profiling.
MATERIALS & METHODS: PBMCs collected from primary health care clinic attendees (April–November 2022) were cryopreserved and thawed after ~2.5–3 years. Of 150 initial samples stratified by Framingham Risk Score (FRS) (low, moderate and high), 80 with ≥70% viability were analysed (low = 37, moderate = 20, high = 23). Flow cytometry was performed using antibodies against CD14, CD16, CD86, and CCR2, with subset gating based on CD14/CD16 expression. Cell viability was assessed via 7-AAD exclusion and hemacytometry.
RESULTS: Cell viability post-thaw ranged from 80% to 99%, with no significant differences across collection months. Monocyte subset distributions remained consistent: classical (3–12%), intermediate (0.3–7%), and non-classical (0.3–15%) across different months. CCR2 expression within subsets showed minimal variation. No clear trend was observed in subset percentages across cardiovascular risk groups, but monocyte subset integrity was preserved throughout storage duration.
CONCLUSION: Long-term cryopreservation preserves PBMC viability and monocyte subset integrity, validating their use in retrospective immunophenotyping. These findings support incorporating monocyte subset analysis with traditional risk scores to improve CVD prediction, especially in studies utilising biobanked samples.
KEYWORDS: Monocyte Subsets, PBMCs, Cryopreservation, Cardiovascular Disease, Flow Cytometry, Framingham Risk Score


